Stay updated on BLASST-1: Nivolumab Combo in MIBC Clinical Trial

Sign up to get notified when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study record page now displays a fetch error instead of a 403 Forbidden response, and the NIH transition notice is no longer shown.
    Difference
    1%
    Check dated 2026-11-07T13:51:16.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s site revision number changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:34:12.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T15:10:56.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer’s site revision changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T14:47:07.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1; the page still displays a 403 error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-10T15:45:13.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    A 403 Forbidden message appears in place of the clinical study record, with a Home button below it.
    Difference
    0.5%
    Check dated 2026-10-03T15:53:57.000Z thumbnail image

Stay in the know with updates to BLASST-1: Nivolumab Combo in MIBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.